CCR2/CCL2-mediated inflammation protects photoreceptor cells from amyloid-β-induced apoptosis

Neurobiology of Disease

Volumn 42, Issue 1, 2011, Pages 55-72

  Bruban, Julien ^a   Maoui, Agathe ^a   Chalour, Naïma ^a   An, Na ^a   Jonet, Laurent ^a   Feumi, Charles ^a   Tréton, Jacques ^a   Sennlaub, Florian ^a   Behar Cohen, Francine ^a   Mascarelli, Frédéric ^b,c   Dinet, Virginie ^b  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c U872   (France)

Author keywords

Age related macular degeneration; Alzheimer's disease; Inflammation; Microglial cells; Oxidative stress; Retina

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CHEMOKINE RECEPTOR CCR2; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOVERIN; RHODOPSIN; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION; MALE; MICROGLIA; MOUSE; NERVE CELL CULTURE; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PHOTORECEPTOR; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA CELL; RETINA DEGENERATION; RETINITIS; UPREGULATION;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CHEMOKINE CCL2; CYTOPROTECTION; HUMANS; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PHOTORECEPTOR CELLS, VERTEBRATE; RECEPTORS, CCR2;

EID: 79751533971     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.01.004     Document Type: Article

References (82)

1. Adler R. Preparation, enrichment and growth of purified cultures of neurons and photoreceptors from chick embryos and from normal and mutant mice. Meth. Neurosciences. 1990, 2:134-150.
2. Ajmone-Cat M.A., Bernardo A., Greco A., Minghetti L. Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions. Pharmaceuticals 2010, 3:1949-1965.
3. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn B.C., Kuziel W.A., Rollins B.J., Ambati B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 2003, 9:1390-1397.
4. Anderson D.H., Mullins R.F., Hageman G.S., Johnson L.V. A role of local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 2002, 134:411-431.
5. Anderson D.H., Talaga K.C., Rivest A.J., Barron E., Hageman G.S., Johnson L.V. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp. Eye Res. 2004, 78:243-256.
6. Ard M.D., Cole G.M., Wei J., Mehrle A.P., Fratkin J.D. Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 1996, 43:190-202.
7. Awasthi A., Matsunaga Y., Yamada T. Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides. Exp. Neurol. 2005, 196:282-289.
8. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000, 45:115-134.
9. Brazil M.I., Chung H., Maxfield F.R. Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia. J. Biol. Chem. 2000, 275:16941-16947.
10. Brown J., Hacker H., Schuschereba S., Zwick H., Lund D., Stuck B. Steroidal and nonsteroidal antiinflammatory medications can improve photoreceptor survival after laser retinal photocoagulation. Ophthalmology 2007, 114:1876-1883.
11. Bruban J., Dinet V., Sennlaub E., Jonet L., Mascarelli F. Amyloid beta (1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell 2009, 8:162-177.
12. Chen J., Flannery J.G., LaVail M.M., Steinberg R.H., Xu J., Simon M.I. Bcl-2 overexpression reduces apoptotic receptor cell death in three different retinal degenerations. Proc. Natl Acad. Sci. USA 1996, 93:7042-7047.
13. Combadière C., Feumi C., Raoul W., Keller N., Rodéro M., Pézard A., Lavalette S., Houssier M., Jonet L., Picard E., Debré P., Sirinyan M., Deterre P., Ferroukhi T., Cohen S.Y., Chauvaud D., Jeanny J.C., Chemtob S., Behar-Cohen F., Sennlaub F. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest. 2007, 117:2920-2928.
14. Czirr E., Weggen S. Gamma-secretase modulation with Abeta42-lowering nonsteroidal anti-inflammatory drugs and derived compounds. Neurodegener. Dis. 2006, 3:298-304.
15. Dentchev T., Milam A.H., Lee V.M., Trojanowski J.Q., Dunaief J.L. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol. Vis. 2003, 9:184-190.
16. Ding J.D., Lin J., Mace B.E., Herrmann R., Sullivan P., Bowes Rickman C. Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Vis. Res. 2008, 48:339-345.
17. Donoso L.A., Kim D., Frost A., Callahan A., Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2006, 51:137-152.
18. Dunaief J.L., Dentchev T., Ying G.S., Milam A.H. The role of apoptosis in age-related macular degeneration. Arch. Ophthalmol. 2002, 20:1435-1442.
19. Dutescu R.M., Li Q.X., Crowston J., Masters C.L., Baird P.N., Culvenor J.G. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247:1213-1221.
20. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
21. El Khoury J., Luster A.D. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications. Trends Pharmacol. Sci. 2008, 29:626-632.
22. El Khoury J., Toft M., Hickman S.E., Means T.K., Terada K., Geula C., Luster A.D. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 2007, 13:432-438.
23. Evans J.R. Risk factors for age-related macular degeneration. Prog. Retin. Eye Res. 2001, 20:227-253.
24. Ferrer I., Boada Rovira M., Sánchez Guerra M.L., Rey M.J., Costa-Jussá F. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol. 2004, 1:11-20.
25. Friedman D.S., O'Colmain B.J., Munoz B., Tomany S.C., McCarty C., de Jong P.T., Nemesure B., Mitchell P., Kempen J. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004, 122:564-572.
26. Glabe C.G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 2006, 27:570-575.
27. Glotin A.L., Debacq-Chainiaux F., Brossas J.Y., Faussat A.M., Treton J., Zubielewicz A., Toussaint O., Mascarelli F. Prematurely senescent ARPE-19 cells display features of age-related macular degeneration. Free Radic. Biol. Med. 2008, 44:1348-1361.
28. Green W.R. Histopathology of age-related macular degeneration. Mol. Vis. 1999, 3:27-33.
29. Guo L., Salt T.E., Luong V., Wood N., Cheung W., Maass A., Ferrari G., Russo-Marie F., Sillito A.M., Cheetham M.E., Moss S.E., Fitzke F.W., Cordeiro M.F. Targeting amyloid-beta in glaucoma treatment. Proc. Natl Acad. Sci. USA 2007, 104:13444-13449.
30. Gupta N., Brown K.E., Milam A.H. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Ex. Eye Res. 2003, 76:463-471.
31. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci. USA 2005, 102:7227-7232.
32. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
33. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., Ufret R.L., Salomon R.G., Perez V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 2008, 14:194-198.
34. Imbimbo B.P. Therapeutic potential of gamma-secretase inhibitors and modulators. Curr. Top. Med. Chem. 2008, 8:54-61.
35. Johnson L.V., Leitner W.P., Rivest A.J., Staples M.K., Radeke M.J., Anderson D.H. The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl Acad. Sci. USA 2002, 99:11830-11835.
36. Johnson P.T., Lewis G.P., Talaga K.C., Brown M.N., Kappel P.J., Fisher S.K., Anderson D.H., Johnson L.V. Drusen associated degeneration in retina. Invest Ophthalmol Vis Sci. 2003, 44:4481-4488.
37. Johnson P.T., Brown M.N., Pulliam B.C., Anderson D.H., Johnson L.V. Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen. Invest Ophthalmol Vis Sci. 2005, 46:4788-4795.
38. Jucker M., Heppner F.L. Cerebral and peripheral amyloid phagocytes-an old liaison with a new twist. Neuron 2008, 59:8-10.
39. Kim H.S., Lee J.H., Lee J.P., Kim E.M., Chang K.A., Park C.H., Jeong S.J., Wittendorp M.C., Seo J.H., Choi S.H., Suh Y.H. Amyloid beta peptide induces cytochrome C release from isolated mitochondria. NeuroReport 2002, 13:1989-1993.
40. Klein R., Klein B.E., Linton K.L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992, 99:933-943.
41. Klein R., Peto T., Bird A., Vannewkirk M.R. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 2004, 137:486-495.
42. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
43. Koenigsknecht J., Landreth G. Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J. Neurosci. 2004, 24:9838-9846.
44. Kotilinek L.A., Westerman M.A., Wang Q., Panizzon K., Lim G.P., Simonyi A., Lesne S., Falinska A., Younkin L.H., Younkin S.G., Rowan M., Cleary J., Wallis R.A., Sun G.Y., Cole G., Frautschy S., Anwyl R., Ashe K.H. Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain 2008, 131:651-664.
45. Lambert M.P., Barlow A.K., Chromy B.A., Ewards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Kraft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 1998, 95:6448-6453.
46. Liang F.Q., Godley B.F. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp. Eye Res. 2003, 76:397-403.
47. Loffler K.U., Edward D.P., Tso M.O. Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. Invest Ophthalmol Vis Sci. 1995, 36:24-31.
48. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 1998, 187:601-608.
49. Luibl V., Isas J.M., Kayed R., Glabe C.G., Langen R., Chen J. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J. Clin. Invest. 2006, 116:378-385.
50. Montezuma S.R., Sobrin L., Seddon J.M. Review of genetics in aged-related macular degeneration. Semin. Ophthalmol. 2007, 22:229-240.
51. Moore B.B., Paine R., Christensen P.J., Moore T.A., Sitterding S., Ngan R., Wilke C.A., Kuziel W.A., Toews G.B. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J. Immunol. 2001, 167:4368-4377.
52. Morais Cardoso S., Swerdlow R.H., Oliveira C.R. Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. Brain Res. 2002, 931:117-125.
53. Morgan D., Gordon M.N., Tan J., Wilcock D., Rojiani A.M. Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J. Neuropathol. Exp. Neurol. 2005, 64:743-753.
54. Movsesyan V.A., Stoica B.A., Faden A.I. MGLuR5 activation reduces β-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor. J. Neurochem. 2004, 89:1528-1536.
55. Nicoll J.A., Wilkinson D., Holmes C., Steart P., Markham H., Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med. 2003, 4:448-452.
56. Ning A., Cui J., To E., Ashe K.H., Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci. 2008, 49:5136-5143.
57. Paquet-Durand F., Silva J., Talukdar T., Johnson L.E., Azadi S., van Veen T., Ueffing M., Hauck S.M., Ekström P.A. Excessive activation of PARP contributes to inherited photoreceptor degeneration in the retinal degeneration 1 mouse. J. Neurosci. 2007, 38:10311-10319.
58. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 1997, 17:553-565.
59. Penfold P.L., Madigan M.C., Gillies M.C., Provis J.M. Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res. 2001, 20:385-414.
60. Perez S.E., Lumayag S., Kovacs B., Mufson E.J., Xu S. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. Invest Ophthalmol Vis Sci 2009, 50:793-800.
61. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 1993, 13:1676-1687.
62. Quinones M.P., Ahuja S.K., Jimenez F., Schaefer J., Garavito E., Rao A., Chenaux G., Reddick R.L., Kuziel W.A., Ahuja S.S. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J. Clin. Invest. 2004, 113:856-866.
63. Raoul W., Keller N., Rodéro M., Behar-Cohen F., Sennlaub F., Combadière C. Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells. J. Neuroimmunol. 2008, 198:56-61.
64. Roque R.S., Rosales A.A., Jingjing L., Agarwal N., Al-Ubaidi M.R. Retina-derived microglial cells induce photoreceptor cell death in vitro. Brain Res. 1999, 836:110-119.
65. Schenk D.B., Yednock T. The role of microglia in Alzheimer's disease: friend or foe?. Neurobiol. Aging 2002, 23:677-679.
66. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 2006, 7:311-317.
67. Seth A., Cui J., To E., Kwee M., Matsubara J. Complement-associated deposits in the human retina. Invest Ophthalmol Vis Sci. 2008, 49:743-750.
68. Shen J.K., Dong A., Hackett S.F., Bell W.R., Green W.R., Campochiaro P.A. Oxidative damage in age-related macular degeneration. Histol. Histopathol. 2007, 22:1301-1308.
69. Simard A., Soulet D., Gowing G., Julien J.-P., Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006, 94:489-502.
70. Su J.H., Kesslak J.P., Head E., Cotman C.W. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain. Acta Neuropathol. 2002, 104:1-6.
71. Tacke F., Alvarez D., Kaplan T.J., Jakubzick C., Spanbroek R., Llodra J., Garin A., Liu J., Mack M., van Rooijen N., Lira S.A., Habenicht A.J., Randolph G.J. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 2007, 117:185-194.
72. Tamagno E., Robino G., Obbili A., Bardini P., Aragno M., Parola M., Danni O. H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp. Neurol. 2003, 180:144-155.
73. Town T., Tan J., Mullan M. CD40 signaling and Alzheimer's disease pathogenesis. Neurochem. Int. 2001, 39:371-380.
74. Vingerling J.R., Dielemans I., Hofman A., Grobbee D.E., Hijmering M., Kramer C.F., de Jong P.T. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995, 102:205-210.
75. Walker D.G., Lue L.F. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases. J. Neurosci. Res. 2005, 81:412-425.
76. Walsh D.T., Montero R.M., Bresciani L.G., Jen A.Y., Leclerq P.D., Saunders D., El-Emir A.N., Gbadamoshi L., Gentleman S.M., Jen L.S. Amyloid-Beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol. Dis. 2002, 10:20-27.
77. Walsh D.T., Bresciani L.G., Saunders D., Manca M.F., Jen A.Y., Gentleman S.M., Jen L.S. Amyloid beta peptide causes chronic glial cell activation and neurodegeneration after intravitreal injection. Neuropathol. Appl. Neurobiol. 2005, 31:491-502.
78. Webster S.D., Yang A.J., Margol L., Garzon-Rodriguez W., Glabe C.G., Webster Tenner A.J., SD Yang A.J., Margol L., Garzon-Rodriguez W., Glabe C.G., Tenner A.J. Complement component C1q modulates the phagocytosis of Abeta by microglia. Exp. Neurol. 2000, 161:127-138.
79. Winkler B.S., Boulton M.E., Gottsch J.D., Sternberg P. Oxidative damage and age-related macular degeneration. Mol. Vis. 1999, 5:32.
80. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response. Nat. Med. 2006, 12:1005-1015.
81. Yoshida T., Ohno-Matsui K., Ichinose S., Sato T., Iwata N., Saido T.C., Hisatomi T., Mochizuki M., Morita I. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J. Clin. Invest. 2005, 115:2793-2800.
82. Zarbin A.M. Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol. 2004, 122:598-614.